The scheme could launch as early as next month.

Sir Jeremy Farrar said vaccinating the whole population, including children, could help to avoid further restrictions.

People who have been fully vaccinated against coronavirus -- right now that means with two doses of either the Pfizer/BioNTech or Moderna vaccine -- can skip quarantine if they are exposed to someone infected with the virus, CDC said...

It is possible, experts say, that COVID-19 could become a seasonal illness, like the flu.

Cathay Pacific is no longer requiring first & business class passengers to wear masks when their seats are fully reclined and in bed mode.

The veteran medic described himself as 'conscientious objector' who disagrees with how authorities have handled the virus

While that trial is thirty days away, experts are encouraging people to sign up now.

The son of former deceased chief justice Sat Sharma, Dr Keshav Raman Sharma, has died in Ireland where he worked, six days after receiving a Covid-19 injection.

The trial conducted at Oxford University and its partner sites is the first to assess the jab's efficacy in children aged 6-17.

The clinical trial involving 300 child volunteers will assess whether the jab - known as the the ChAdOx1 nCoV-19 vaccine - will produce a strong immune response.

Amid concerns of low vaccination rates in city's eastern sector, Moshe Lion tells local leaders that residents who aren't inoculated may be prevented from entering some places

The certificates will verify Covid inoculations and will be developed by the government, following the likes of Greece, Spain, Poland, Iceland and Portugal to commit to similar schemes.

When the next coronavirus pandemic hits, scientists plan to already have a vaccine against it, no matter what it is. But how is that possible? Here’s what they’re doing now to develop vaccines against emerging viruses and future variants of COVID-19.

Vulnerable people have encountered ‘shocking discrimination’ during pandemic, says Mencap charity

They already have some immunity and a single dose will "act as a booster", the health agency says.

AstraZeneca, which produces the Oxford vaccine, says it is expanding trials to children as young as six and Janssen is looking into testing new born babies.